SEC Correspondence
MEDOVEX CORP.
1950 Airport Road, Suite A
Atlanta, GA 30341
May 3,
2017
Securities
and Exchange Commission
Division
of Corporate Finance
100 F
Street, NE
Washington,
D.C. 20549
Attn:
Amanda Ravitz, Esq., Branch Chief--Legal
Re:
Medovex Corp.
Amendment
No. 1 to Registration Statement on Form S-3
Filed
May 2, 2017
File
No. 333-217411
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations under the
Securities Act of 1933, as amended, Medovex Corp. (the
“Company”) respectfully requests that the effective
date of the registration statement referred to above be accelerated
so that it will become effective at 4:15 p.m., Eastern Standard
Time, on May 5, 2017, or as soon thereafter as
possible.
The
Company hereby acknowledges the following:
●
that should the
Commission or the staff, acting pursuant to delegated authority,
declare the filing effective, it does not foreclose the Commission
from taking any action with respect to the filing;
●
the action of the
Commission or the staff, acting pursuant to delegated authority, in
declaring the filing effective, does not relieve the Company from
its full responsibility for the adequacy and accuracy of the
disclosure in the filing; and
●
the Company may not
assert staff comments and the declaration of effectiveness as a
defense in any proceeding initiated by the Commission or any person
under the federal securities laws of the United
States.
MEDOVEX
CORP.
By:
/s/ Jarrett
Gorlin
Name:
Jarrett Gorlin
Title:
Chief Executive Officer